Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Cancer Reports (Hoboken, N.J.)|April 25, 2024
Senolysis of gemcitabine-induced senescent human pancreatic cancer cellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Oncology Reports|November 17, 2011
Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecumKousuke Tanaka, Yasunori Matsui, Satoru Ishikawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
International Journal of Oncology|September 6, 2005
Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor typesYoshimi Arima, Satoko Matsueda, Hirohisa Yano, et al.
Oncotarget|April 24, 2018
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino, Yukari Tsubata, Nanae Harashima, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2009
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinomaMiki Tongu, Nanae Harashima, Takaya Yamada, et al.
Plos One|May 23, 2015
The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer CellsMin Zhang, Nanae Harashima, Tamami Moritani, et al.
Cancer Science|November 4, 2014
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing stateMiki Tongu, Nanae Harashima, Koji Tamada, et al.
Immunology|September 11, 2009
Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathiesMasahiro Kondo, Yohko Murakawa, Nanae Harashima, et al.
Cancer Science|August 21, 2020
Immunogenic chemotherapy in two mouse colon cancer modelsTakahito Taniura, Yuichi Iida, Hitoshi Kotani, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Cancer Reports (Hoboken, N.J.)|April 25, 2024
Senolysis of gemcitabine-induced senescent human pancreatic cancer cellsMohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, et al.
Oncology Reports|November 17, 2011
Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecumKousuke Tanaka, Yasunori Matsui, Satoru Ishikawa, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Vaccination of cytotoxic T lymphocyte-directed peptides elicited and spread humoral and Th1-type immune responses to prostate-specific antigen protein in a prostate cancer patientMamoru Harada, Satoko Matsueda, Akihisa Yao, et al.
International Journal of Oncology|September 6, 2005
Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor typesYoshimi Arima, Satoko Matsueda, Hirohisa Yano, et al.
Oncotarget|April 24, 2018
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancerRyosuke Tanino, Yukari Tsubata, Nanae Harashima, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2009
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinomaMiki Tongu, Nanae Harashima, Takaya Yamada, et al.
Plos One|May 23, 2015
The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer CellsMin Zhang, Nanae Harashima, Tamami Moritani, et al.
Cancer Science|November 4, 2014
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing stateMiki Tongu, Nanae Harashima, Koji Tamada, et al.
Immunology|September 11, 2009
Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatory myopathiesMasahiro Kondo, Yohko Murakawa, Nanae Harashima, et al.
Cancer Science|August 21, 2020
Immunogenic chemotherapy in two mouse colon cancer modelsTakahito Taniura, Yuichi Iida, Hitoshi Kotani, et al.
Pageof 11